204 related articles for article (PubMed ID: 17328083)
1. Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
van der Heijde D; Klareskog L
Arthritis Rheum; 2007 Mar; 56(3):1031-2. PubMed ID: 17328083
[No Abstract] [Full Text] [Related]
2. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.
Yazici Y; Yazici H
Arthritis Rheum; 2006 Sep; 54(9):3061-2. PubMed ID: 16948140
[No Abstract] [Full Text] [Related]
3. [Therapy of rheumatoid arthritis with etanercept].
Lamprecht P; Nitschmann S
Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
[No Abstract] [Full Text] [Related]
4. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
van der Heijde D; Klareskog L; Landewé R; Bruyn GA; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
Arthritis Rheum; 2007 Dec; 56(12):3928-39. PubMed ID: 18050208
[TBL] [Abstract][Full Text] [Related]
5. COMET's path, and the new biologicals in rheumatoid arthritis.
Kremer JM
Lancet; 2008 Aug; 372(9636):347-8. PubMed ID: 18635257
[No Abstract] [Full Text] [Related]
6. Etanercept improves rheumatoid arthritis partially responsive to methotrexate.
Cutolo M
Clin Exp Rheumatol; 2001; 19(6):626-7. PubMed ID: 11791631
[No Abstract] [Full Text] [Related]
7. Dosage and mode of administration of methotrexate in clinical trials: comment on the article by Genovese et al.
Seitz M; Villiger PM
Arthritis Rheum; 2003 Mar; 48(3):863. PubMed ID: 12632454
[No Abstract] [Full Text] [Related]
8. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Landewé R; van der Heijde D; Klareskog L; van Vollenhoven R; Fatenejad S
Arthritis Rheum; 2006 Oct; 54(10):3119-25. PubMed ID: 17009230
[TBL] [Abstract][Full Text] [Related]
9. A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.
Kameda H; Kanbe K; Sato E; Ueki Y; Saito K; Nagaoka S; Hidaka T; Atsumi T; Tsukano M; Kasama T; Shiozawa S; Tanaka Y; Yamanaka H; Takeuchi T;
Ann Rheum Dis; 2013 Feb; 72(2):310-2. PubMed ID: 22975754
[No Abstract] [Full Text] [Related]
10. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
[TBL] [Abstract][Full Text] [Related]
11. Overlap of systemic sclerosis and rheumatoid arthritis.
Alkassab F
J Rheumatol; 2007 Jul; 34(7):1593-4. PubMed ID: 17611965
[No Abstract] [Full Text] [Related]
12. Etanercept in rheumatoid arthritis.
Cook DA; Dimick JB; Gallagher DC
N Engl J Med; 1999 Jun; 340(25):2000; author reply 2001. PubMed ID: 10383273
[No Abstract] [Full Text] [Related]
13. Tumor necrosis factor alpha inhibitors, methotrexate or both? An inquiry into the formal evidence for when they are to be used in rheumatoid arthritis.
Yazici Y; Yazici H
Clin Exp Rheumatol; 2008; 26(3):449-52. PubMed ID: 18578967
[TBL] [Abstract][Full Text] [Related]
14. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial.
Emery P; Breedveld FC; Hall S; Durez P; Chang DJ; Robertson D; Singh A; Pedersen RD; Koenig AS; Freundlich B
Lancet; 2008 Aug; 372(9636):375-82. PubMed ID: 18635256
[TBL] [Abstract][Full Text] [Related]
15. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.
Weinblatt ME; Kremer JM; Bankhurst AD; Bulpitt KJ; Fleischmann RM; Fox RI; Jackson CG; Lange M; Burge DJ
N Engl J Med; 1999 Jan; 340(4):253-9. PubMed ID: 9920948
[TBL] [Abstract][Full Text] [Related]
16. Improvements in clinical response between 12 and 24 weeks in patients with rheumatoid arthritis on etanercept therapy with or without methotrexate.
Kavanaugh A; Klareskog L; van der Heijde D; Li J; Freundlich B; Hooper M
Ann Rheum Dis; 2008 Oct; 67(10):1444-7. PubMed ID: 18535115
[TBL] [Abstract][Full Text] [Related]
17. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
Ann Rheum Dis; 2006 Mar; 65(3):328-34. PubMed ID: 16079172
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
Weinblatt ME; Keystone EC; Cohen MD; Freundlich B; Li J; Chon Y; Baumgartner SW
J Rheumatol; 2011 Feb; 38(2):242-6. PubMed ID: 21078715
[TBL] [Abstract][Full Text] [Related]
19. Conventional triple therapy as good as etanercept for uncontrolled rheumatoid arthritis.
BMJ; 2013 Jun; 346():f3846. PubMed ID: 23778977
[No Abstract] [Full Text] [Related]
20. Etanercept in rheumatoid arthritis.
Ferraccioli GF; Di Poi E
N Engl J Med; 1999 Jun; 340(25):2000-1. PubMed ID: 10383275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
